Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
8569358
Reference Type
Journal Article
Title
COVID-19 Therapeutic Options Under Investigation
Author(s)
Kaddoura, M; Alibrahim, M; Hijazi, G; Soudani, N; Audi, A; Alkalamouni, H; Haddad, S; Eid, A; Zaraket, H
Year
2020
Journal
Frontiers in Pharmacology
ISSN:
1663-9812
Volume
11
Page Numbers
1196
Language
English
DOI
10.3389/fphar.2020.01196
URL
https://www.proquest.com/scholarly-journals/covid-19-therapeutic-options-under-investigation/docview/2437842624/se-2?accountid=171501
Exit
Abstract
Since its emergence in China in December 2019, COVID-19 has quickly spread around the globe causing a pandemic. Vaccination or the development of herd immunity seems the only way to slow down the spread of the virus; however, both are not achievable in the near future. Therefore, effective treatments to mitigate the burden of this pandemic and reduce mortality rates are urgently needed. Preclinical and clinical studies of potential antiviral and immunomodulatory compounds and molecules to identify safe and efficacious therapeutics for COVID-19 are ongoing. Two compounds, remdesivir, and dexamethasone have been so far shown to reduce COVID-19-associated death. Here, we provide a review of the potential therapeutic agents being considered for the treatment and management of COVID-19 patients.
Keywords
COVID-19; antivirals; SARS-CoV-2; adjunctive therapy; therapeutics
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity